BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Qiu B, Aili A, Xue L, Jiang P, Wang J. Advances in Radiobiology of Stereotactic Ablative Radiotherapy. Front Oncol 2020;10:1165. [PMID: 32850333 DOI: 10.3389/fonc.2020.01165] [Cited by in Crossref: 3] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Vilotte F, Pasquier D, Blanchard P, Supiot S, Khalifa J, Schick U, Lacornerie T, Vieillevigne L, Marre D, Chapet O, Latorzeff I, Magne N, Meyer E, Cao K, Belkacemi Y, Bibault JE, Berge-Lefranc M, Faivre JC, Gnep K, Guimas V, Hasbini A, Langrand-Escure J, Hennequin C, Graff P. Recommendations for stereotactic body radiation therapy for spine and non-spine bone metastases. A GETUG (French society of urological radiation oncolgists) consensus using a national two-round modified Delphi survey. Clin Transl Radiat Oncol 2022;37:33-40. [PMID: 36052019 DOI: 10.1016/j.ctro.2022.08.006] [Reference Citation Analysis]
2 Feng XY, Li J, Li AM, Jing SH, Zhu XX, Wang Z. Stereotactic body radiotherapy for recurrent and oligometastatic soft tissue sarcoma. World J Surg Oncol 2022;20:322. [PMID: 36171617 DOI: 10.1186/s12957-022-02781-1] [Reference Citation Analysis]
3 Li Z, Hu Y, Zeng M, Hu Q, Ye F, Liu R, Cai H, Li Q, Wang X. The role transition of radiotherapy for the treatment of liver cancer in the COVID-19 era. Front Oncol 2022;12:976143. [DOI: 10.3389/fonc.2022.976143] [Reference Citation Analysis]
4 Schiavo F, Kjellsson Lindblom E, Toma-dasu I. Towards the virtual tumor for optimizing radiotherapy treatments of hypoxic tumors: a novel model of heterogeneous tissue vasculature and oxygenation. Journal of Theoretical Biology 2022. [DOI: 10.1016/j.jtbi.2022.111175] [Reference Citation Analysis]
5 Kissel M, Créhange G, Graff P. Stereotactic Radiation Therapy versus Brachytherapy: Relative Strengths of Two Highly Efficient Options for the Treatment of Localized Prostate Cancer. Cancers 2022;14:2226. [DOI: 10.3390/cancers14092226] [Reference Citation Analysis]
6 Mangoni M, Borghesi S, Aristei C, Becherini C. Radiobiology of stereotactic radiotherapy. Rep Pract Oncol Radiother 2022;27:57-62. [PMID: 35402022 DOI: 10.5603/RPOR.a2022.0005] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Fernández C, Navarro-Martin A, Bobo A, Cabrera-Rodriguez J, Calvo P, Chicas-Sett R, Luna J, Rodríguez de Dios N, Couñago F. Single-fraction stereotactic ablative body radiation therapy for primary and metastasic lung tumor: A new paradigm? World J Clin Oncol 2022; 13(2): 101-115 [DOI: 10.5306/wjco.v13.i2.101] [Reference Citation Analysis]
8 Ghaderi N, Jung J, Brüningk SC, Subramanian A, Nassour L, Peacock J. A Century of Fractionated Radiotherapy: How Mathematical Oncology Can Break the Rules. Int J Mol Sci 2022;23:1316. [PMID: 35163240 DOI: 10.3390/ijms23031316] [Reference Citation Analysis]
9 Morilla I, Chan P, Caffin F, Svilar L, Selbonne S, Ladaigue S, Buard V, Tarlet G, Micheau B, Paget V, François A, Souidi M, Martin JC, Vaudry D, Benadjaoud MA, Milliat F, Guipaud O. Deep models of integrated multiscale molecular data decipher the endothelial cell response to ionizing radiation. iScience 2022;25:103685. [PMID: 35106469 DOI: 10.1016/j.isci.2021.103685] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
10 Wang X, Lu Y, Qin Z, Guo H, Chen W, Ding T, Tang J, Zhang H. Stereotactic Body Radiotherapy and Conventional Radiotherapy Induce Cytoskeleton Extension and Enlargement of Cell Morphology in Non-Small Cell Lung Cancer. Dose Response 2021;19:15593258211064499. [PMID: 34987340 DOI: 10.1177/15593258211064499] [Reference Citation Analysis]
11 Ueno M, Takabatake H, Itasaka S, Kayahara T, Morimoto Y, Yamamoto H, Mizuno M. Stereotactic body radiation therapy versus radiofrequency ablation for single small hepatocellular carcinoma: a propensity-score matching analysis of their impact on liver function and clinical outcomes. J Gastrointest Oncol 2021;12:2334-44. [PMID: 34790396 DOI: 10.21037/jgo-21-356] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Steuber T, Maurer T, Miller K. [Metachronous oligometastatic prostate cancer-the more the better or only local treatment?]. Urologe A 2021;60:1534-45. [PMID: 34734294 DOI: 10.1007/s00120-021-01701-7] [Reference Citation Analysis]
13 Christ SM, Ahmadsei M, Wilke L, Kühnis A, Pavic M, Tanadini-Lang S, Guckenberger M. Long-term cancer survivors treated with multiple courses of repeat radiation therapy. Radiat Oncol 2021;16:208. [PMID: 34717664 DOI: 10.1186/s13014-021-01934-y] [Reference Citation Analysis]
14 Xue H, Qiu B, Wang H, Jiang P, Sukocheva O, Fan R, Xue L, Wang J. Stereotactic Ablative Brachytherapy: Recent Advances in Optimization of Radiobiological Cancer Therapy. Cancers (Basel) 2021;13:3493. [PMID: 34298703 DOI: 10.3390/cancers13143493] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Mathew AS, Dawson LA. Current Understanding of Ablative Radiation Therapy in Hepatocellular Carcinoma. J Hepatocell Carcinoma 2021;8:575-86. [PMID: 34164350 DOI: 10.2147/JHC.S284403] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
16 Whitaker J, Mak RH, Zei PC. Non-invasive ablation of arrhythmias with stereotactic ablative radiotherapy. Trends Cardiovasc Med 2021:S1050-1738(21)00052-9. [PMID: 33951498 DOI: 10.1016/j.tcm.2021.04.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]